NanoDx, Inc. is a privately-held, U.S. based, medical device company developing rapid point-of-care and in-vitro diagnostic products on its proprietary nanowire biosensor platform. The NanoDx™ System provides for direct measurement of blood and saliva analytes normally in less than 2 minutes from either a drop of whole blood or a small sample of saliva. In partnership with IBM and SkyWater Technologies, a low-cost, high-volume, licensed CMOS process has been integrated into NanoDx’s highly-advanced proprietary platform. The System consists of a single-use, disposable test cartridge and an analyzer. The company is focused on two near-term indications: traumatic brain injury (TBI) and Covid-19. The NanoDx™ System offers compelling competitive advantages based on its ultra-sensitivity and accuracy, speed, value, and ease-of-use. Additional potential diseases and conditions include stroke, sepsis, influenza and inflammatory diseases.
FDA has not yet reviewed this product and it has not been cleared. Currently for research use only.
Company Details
- Employees
- 40
- Founded
- -
- Address
- 144 Turnpike Rd.,
- Industry
- Medical Device
- Website
- http://www.nanodiagnostics.com
- Keywords
- Traumatic Brain Injury, POC Diagnostics, Concussion, BrainInjury, Neuroscience, Biomarkers, TBI, Medical Device, Mental Health, Nanotechnology, Brain Injury Awareness, Concussion Awareness, Precision Medicine, Diagnostics.
- HQ
- Southborough, MA
Nanodx, Inc. Questions
Nanodx, Inc.'s website is http://www.nanodiagnostics.com
Nanodx, Inc.'s LinkedIn profile is https://www.linkedin.com/company/nanodxinc
Nanodx, Inc. has
40 employees.
View email and phone details for 40
employees at Nanodx, Inc..
Nanodx, Inc.'s industry is
Medical Device
Nanodx, Inc.'s top competitors are
Vertex Pharmaceuticals,
Digital Health Solutions,
Siphox Health,
Iris Kinetics,
Moderna,
Medtronic,
Nano Diagnostics, Llc.,
Ancera,
Abbvie,
Altaeros.
Nanodx, Inc.'s categories are Medical Device
Nanodx, Inc.'s founding year is 2010
